BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 5672561)

  • 1. Ocular effects of phenothiazine derivatives and reversibility.
    Mathalone MB
    Dis Nerv Syst; 1968 Mar; 29(3):Suppl:29-35. PubMed ID: 5672561
    [No Abstract]   [Full Text] [Related]  

  • 2. Ocular complications of phenothiazines.
    Mathalone MB
    Trans Ophthalmol Soc U K (1962); 1966; 86():77-88. PubMed ID: 5226613
    [No Abstract]   [Full Text] [Related]  

  • 3. Ocular complications related to phenothiazines.
    Siddall JR
    Dis Nerv Syst; 1968 Mar; 29(3):Suppl:10-3. PubMed ID: 4876740
    [No Abstract]   [Full Text] [Related]  

  • 4. Prognosis of eye complications caused by phenothiazines.
    Forrest FM; Snow HL
    Dis Nerv Syst; 1968 Mar; 29(3):Suppl:26-8. PubMed ID: 5672560
    [No Abstract]   [Full Text] [Related]  

  • 5. [Complications on the part of the eyes during employment of psychotropic drugs (review of the foreign literature)].
    Gol'dovskaia IL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(6):935-9. PubMed ID: 4905472
    [No Abstract]   [Full Text] [Related]  

  • 6. [Damage to eyes through conservative therapy].
    Kleberger E
    Klin Monbl Augenheilkd; 1967; 151(6):777-801. PubMed ID: 4874408
    [No Abstract]   [Full Text] [Related]  

  • 7. Ocular complications of chlorpromazine therapy.
    Petrohelos MA; Tricoulis D
    Ophthalmologica; 1969; 158 Suppl():469-76. PubMed ID: 4982681
    [No Abstract]   [Full Text] [Related]  

  • 8. [Ocular involvement during prolonged treatment with neuroleptics].
    Nouri A; Cuendet JF
    Schweiz Med Wochenschr; 1968 Oct; 98(43):1708-11. PubMed ID: 4974196
    [No Abstract]   [Full Text] [Related]  

  • 9. Prolonged pharmacotherapy and the eye. A symposium. The antimalarials and the tranquilizers.
    Rubin M
    Dis Nerv Syst; 1968 Mar; 29(3):Suppl:67-76. PubMed ID: 4233735
    [No Abstract]   [Full Text] [Related]  

  • 10. Toxic effects of phenothiazines on the eye.
    Boet DJ
    Doc Ophthalmol; 1970 Jul; 28(1):1-69. PubMed ID: 5312274
    [No Abstract]   [Full Text] [Related]  

  • 11. [Ophthalmologic study of patients receiving psychotropic drugs].
    Gol'dovskaia IL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1970 May; 70(5):759-62. PubMed ID: 5311196
    [No Abstract]   [Full Text] [Related]  

  • 12. [Ultrastructural study of ocular pigmentation due to phenothiazines].
    Sizaret P; Rossazza C; Brassart B
    Rev Otoneuroophtalmol; 1975; 47(4):247-51. PubMed ID: 1215727
    [No Abstract]   [Full Text] [Related]  

  • 13. [Adverse effects of phenothiazines].
    Roos BE
    Nord Psykiatr Tidsskr; 1968; 22(2):97-100. PubMed ID: 5704635
    [No Abstract]   [Full Text] [Related]  

  • 14. Phenothiazine retinopathy.
    Boet DJ
    Ophthalmologica; 1969; 158 Suppl():574-82. PubMed ID: 5359756
    [No Abstract]   [Full Text] [Related]  

  • 15. Electro-oculography as a diagnostic aid in phenothiazin retinopathy.
    Henkes HE
    Trans Ophthalmol Soc U K (1962); 1967; 87():285-7. PubMed ID: 5255224
    [No Abstract]   [Full Text] [Related]  

  • 16. [Ocular and cutaneous changes in patients exposed to prolonged treatment with neuroleptic drugs].
    Francesconi G; Di Tizio A; Cameo D
    Ann Ottalmol Clin Ocul; 1968 Jul; 94(7):835-52. PubMed ID: 4236709
    [No Abstract]   [Full Text] [Related]  

  • 17. Phenothiazines in ophthalmology.
    Siddall JR
    Int Ophthalmol Clin; 1967; 7(1):207-15. PubMed ID: 5599926
    [No Abstract]   [Full Text] [Related]  

  • 18. [The neuroleptic syndrome. Attempted systematization of primary and secondary effects observed during neuroleptic treatments].
    Lambert PA
    Encephale; 1971; 60(4):335-49. PubMed ID: 5004893
    [No Abstract]   [Full Text] [Related]  

  • 19. [Ocular manifestations during treatment with phenothiazine derivatives].
    Ardouin M; Feuvrier YM; Delattre A
    Bull Soc Ophtalmol Fr; 1969 Mar; 69(3):395-401. PubMed ID: 5383905
    [No Abstract]   [Full Text] [Related]  

  • 20. Incidence and significance of chlorpromazine-induced eye changes.
    De Long SL
    Dis Nerv Syst; 1968 Mar; 29(3):Suppl:19-22. PubMed ID: 4876741
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.